We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restor... Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor. Show more
– Aberrant TRIM7 expression identified as a key driver of immune checkpoint blockade (ICB) acquired resistance; inhibition of TRIM7 with small molecule inhibitors may prevent or reverse acquired...
AUSTIN, TX & DURHAM, NC, April 01, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional...
AUSTIN, TX and DURHAM, NC, March 04, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.09 | -0.930713547053 | 9.67 | 10.31 | 8.85 | 294120 | 9.75701509 | CS |
4 | -0.23 | -2.34454638124 | 9.81 | 10.31 | 8.56 | 257694 | 9.36992702 | CS |
12 | -0.32 | -3.23232323232 | 9.9 | 11.11 | 8.06 | 328594 | 9.25369534 | CS |
26 | 8.16 | 574.647887324 | 1.42 | 11.11 | 1.36 | 975315 | 6.33703492 | CS |
52 | 6.78 | 242.142857143 | 2.8 | 11.11 | 1.3301 | 503641 | 6.20882629 | CS |
156 | -20.05 | -67.6679041512 | 29.63 | 38.9 | 1.3301 | 281203 | 8.39891628 | CS |
260 | -9.03 | -48.5222998388 | 18.61 | 60.5162 | 1.3301 | 266223 | 11.12549656 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions